SEARCH

SEARCH BY CITATION

References

  • 1
    Kamo K, Katanoda K, Matsuda T, Marugame T, Ajiki W, Sobue T. Lifetime and age-conditional probabilities of developing or dying of cancer in Japan. Jpn J Clin Oncol 2008; 38: 5716.
  • 2
    Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol 2011; 41: 4051.
  • 3
    Soerjomataram I, Coebergh JW. Epidemiology of multiple primary cancers. Methods Mol Biol 2009; 471: 85105.
  • 4
    Tsukuma H, Fujimoto I, Hanai A, Hiyama T, Kitagawa T, Kinoshita N. Incidence of second primary cancers in Osaka residents, Japan, with special reference to cumulative and relative risks. Jpn J Cancer Res 1994; 85: 33945.
  • 5
    Boice JD Jr, Storm HH, Curtis RE et al. Introduction to the study of multiple primary cancers. Natl Cancer Inst Monogr 1985; 68: 39.
  • 6
    Fujimoto I, Hanai A, Hiyama T, Tsukuma H, Takasugi Y, Sugaya T. Cancer Incidence and Mortality in Osaka 1963–1989. Tokyo: Shinohara Publishers, 1993 (in Japanese).
  • 7
    World Health Organization. International Statistical Classification of Diseases and Health Related Problems (The) ICD-10 Second Edition. Geneva: World Health Organization, 2004.
  • 8
    Ajiki W, Koyama Y, Kinoshita N, Tsukuma H, Oshima A. The comprehensive study for multiple primary cancers based on the hospital cancer registry data of the Osaka Medical Centre for Cancer and Cardiovascular Diseases. In: Tsukuma H, ed. The Report for Grant-in-Aid for Cancer Research (12–4) from the Ministry of Health, Labour and Welfare. Osaka: Suehiro Publishers, 2000; 11126 (in Japanese).
  • 9
    Day NE. Cumurative rate and cumulative risk. In: Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Cancer Incidence In Five Continents Volume VI. Lyon: IARC, 1992; 8624.
  • 10
    International Agency for Research on Cancer (IARC). International Rules for Multiple Primary Cancers (ICD-O 3rd edn). Lyon: IARC, 2004.
  • 11
    World Health Organization (WHO). International Classification of Diseases for Oncology (ICD-O), 3rd edn. Geneva: WHO, 2000.
  • 12
    Youlden DR, Baade PD. The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study. BMC Cancer 2011; 11: 83.
  • 13
    Cooley ME, Sarna L, Kotlerman J et al. Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer 2009; 66: 21825.
  • 14
    Sandeep TC, Strachan MW, Reynolds RM et al. Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab 2006; 91: 181925.
  • 15
    Engeland A, Bjorge T, Haldorsen T, Tretli S. Use of multiple primary cancers to indicate associations between smoking and cancer incidence: an analysis of 500 000 cancer cases diagnosed in Norway during 1953–93. Int J Cancer 1997; 70: 4017.
  • 16
    Nasca P, Pastides H. Fundamentals of Cancer Epidemiology, 2nd edn. Ontario: Jones and Bartlett Publishers, 2008.
  • 17
    Adami HO, Hunter D, Trichopoulos D. Textbook of Cancer Epidemiology, 2nd edn. New York: Oxford University Press, 2008.
  • 18
    Wakai K, Inoue M, Mizoue T et al. Tobacco smoking and lung cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 2006; 36: 30924.
  • 19
    Wynder EL, Mushinski MH, Spivak JC. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer 1977; 40: 18728.
  • 20
    Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 2004; 95: 74552.
  • 21
    Reulen RC, Frobisher C, Winter DL et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 2011; 305: 23119.
  • 22
    Kuligina E, Reiner A, Imyanitov EN, Begg CB. Evaluating cancer epidemiologic risk factors using multiple primary malignancies. Epidemiology 2010; 21: 36672.
  • 23
    Dong C, Hemminki K. Second primary neoplasms in 633 964 cancer patients in Sweden, 1958–1996. Int J Cancer 2001; 93: 15561.
  • 24
    Curado M, Edwards B, Shin H et al. Cancer Incidence in Five Continents, Vol. IX. Lyon: International Agency for Research on Cancer, 2007.
  • 25
    Curtis RE, Boice JD Jr, Kleinerman RA, Flannery JT, Fraumeni JF Jr. Summary: multiple primary cancers in Connecticut, 1935–82. Natl Cancer Inst Monogr 1985; 68: 21942.
  • 26
    Meadows AT, Friedman DL, Neglia JP et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009; 27: 235662.
  • 27
    Curtis RE, Freedman D, Ron E et al. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973–2000. NIH Publication no. 05–5302. Bethesda: National Cancer Institute, 2006.